Topical Corticosteroid (TCS) — Competitive Intelligence Brief

Topical Corticosteroid (TCS) (Topical Corticosteroid (TCS)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical corticosteroid. Area: Dermatology.

phase 3 Topical corticosteroid Dermatology Small molecule

Target snapshot

Topical Corticosteroid (TCS) (Topical Corticosteroid (TCS)) — Eli Lilly and Company. Topical corticosteroids reduce inflammation by suppressing the immune system's response to perceived threats.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Topical Corticosteroid (TCS) TARGET	Topical Corticosteroid (TCS)	Eli Lilly and Company	phase 3	Topical corticosteroid
Clobetasol Ointment	Clobetasol Ointment	National Institute of Allergy and Infectious Diseases (NIAID)	marketed	Topical corticosteroid (Class I/super-potent)	Glucocorticoid receptor
Prednisolone acetate eye drops	Prednisolone acetate eye drops	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	marketed	Topical corticosteroid	Glucocorticoid receptor
local mometasone furoate treatment	local mometasone furoate treatment	University Hospital, Ghent	marketed	Topical corticosteroid	Glucocorticoid receptor
Fluticasone Propionate Cream 0.05%	Fluticasone Propionate Cream 0.05%	Netherlands Institute for Pigment Disorders	marketed	Topical corticosteroid	Glucocorticoid receptor
IDP-118 Lotion	IDP-118 Lotion	Bausch Health Americas, Inc.	marketed	Topical corticosteroid	Glucocorticoid receptor
Clobetasol propionate foam	Clobetasol propionate foam	Stiefel, a GSK Company	marketed	Topical corticosteroid (Class I, super-potent)	Glucocorticoid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical corticosteroid class)

1. LEO Pharma · 3 drugs in this class
2. Pierre Fabre Medicament · 2 drugs in this class
3. GlaxoSmithKline · 2 drugs in this class
4. Promius Pharma, LLC · 2 drugs in this class
5. Astellas Pharma Inc · 1 drug in this class
6. Astion Pharma A/S · 1 drug in this class
7. Al-Azhar University · 1 drug in this class
8. BUZZZ Pharmaceuticals Limited · 1 drug in this class
9. Apotex Inc. · 1 drug in this class
10. Aswan University Hospital · 1 drug in this class